- Home
- NKSH vs ARCT Comparison
NKSH vs ARCT Comparison
Compare NKSH & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKSH | ARCT |
|---|---|---|
| Founded | 1891 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.2M | 194.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NKSH | ARCT |
|---|---|---|
| Price | $32.95 | $7.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.67 |
| AVG Volume (30 Days) | 13.0K | ★ 892.4K |
| Earning Date | 01-22-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.50% | N/A |
| EPS Growth | ★ 41.35 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | $51,980,000.00 | ★ $97,601,000.00 |
| Revenue This Year | $2.95 | N/A |
| Revenue Next Year | $9.97 | N/A |
| P/E Ratio | $16.43 | ★ N/A |
| Revenue Growth | ★ 19.63 | N/A |
| 52 Week Low | $23.75 | $5.85 |
| 52 Week High | $33.92 | $24.17 |
Technical Indicators
Market Signals| Indicator | NKSH | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 73.37 | 43.19 |
| Support Level | $29.79 | $7.04 |
| Resistance Level | $30.72 | $7.76 |
| Average True Range (ATR) | 0.92 | 0.39 |
| MACD | 0.40 | 0.45 |
| Stochastic Oscillator | 96.46 | 84.98 |
Price Performance
Historical ComparisonAbout NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.